R-Mini-CHOP Versus R-Bendamustine As Primary Treatment for Diffuse Large B-Cell Lymphoma (DLBCL) in Elderly and Comorbid Patients

被引:5
|
作者
Hammersen, Jakob [1 ]
Ruethrich, Maria Madeleine [2 ]
Kleber, Martina [3 ]
Wedding, Ulrich [2 ]
Sommer, Michael [4 ]
Mueller, Daniela [2 ]
Schlattmann, Peter [2 ]
Hochhaus, Andreas [2 ]
La Rosee, Paul [2 ]
机构
[1] Univ Hosp, Jena, Germany
[2] Univ Hosp Jena, Jena, Germany
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Universityhosp Jena, Jena, Germany
关键词
D O I
10.1182/blood.V124.21.5436.5436
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] CHOP-R plus bortezomib as initial therapy for diffuse large B-cell lymphoma (DLBCL)
    Leonard, J. P.
    Furman, R. R.
    Cheung, Y. K.
    Vose, J. M.
    Glynn, P. W.
    Ruan, J.
    Martin, P.
    Niesvizky, R.
    LaCasce, A.
    Chadburn, A.
    Coleman, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [12] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [13] A single institution analysis of R-CHOP-14 vs.-21 in diffuse large B-cell lymphoma (DLBCL) in elderly patients
    Ruethrich, M. M.
    Hammersen, F. J.
    Hochhaus, A.
    La Rosee, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 36 - 36
  • [14] Dose attenuation of R-CHOP for the treatment of elderly patients with diffuse large B cell lymphoma
    Choi, Young Jin
    Lee, Kyung Woo
    Shin, Ho-Jin
    Chung, Jooseop
    Cho, Goon-Jae
    BLOOD, 2007, 110 (11) : 184B - 184B
  • [15] DOSE ATTENUATION OF R-CHOP FOR THE TREATMENT OF ELDERLY PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
    Choi, Y. J.
    Chung, J. S.
    Lee, K. W.
    Shin, H. J.
    Cho, G. J.
    Song, M. K.
    Seol, Y. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 502 - 502
  • [16] Diffuse large B-cell lymphoma: R-CHOP forever?
    Jedrzejczak, Wieslaw W.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (10): : 713 - 714
  • [17] Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOP
    Mondello, Patrizia
    Mian, Michael
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 333 - 344
  • [18] Phase I Trial of Carfilzomib plus R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Hill, Brian T.
    Dean, Robert M.
    Jagadeesh, Deepa
    Garcia, Alex V. Mejia
    Pohlman, Brad
    Winter, Allison M.
    Krauspe, Ethan
    Collier, Patrick
    D'Andrea, Christopher
    Morrison, Ashley
    Lehmann, Sarah
    Tomlinson, Benjamin K.
    Cooper, Brenda
    de Lima, Marcos
    Ondrejka, Sarah L.
    Hsi, Eric D.
    Caimi, Paolo
    BLOOD, 2018, 132
  • [19] A New Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Miura, Katsuhiro
    Konishi, Jun
    Miyake, Takaaki
    Masanori, Makita
    Hojo, Atsuko
    Masaki, Yasufumi
    Uno, Masatoshi
    Ozaki, Jun
    Yoshida, Chikamasa
    Niiya, Daigo
    Kitazume, Koichi
    Maeda, Yoshinobu
    Takizawa, Jun
    Sakai, Rika
    Nawa, Yuichiro
    Yano, Tomofumi
    Yamamoto, Kazuhiko
    Sunami, Kazutaka
    Hiramatsu, Yasushi
    Aoyama, Kazutoshi
    Tsujimura, Hideki
    Hatta, Yoshihiro
    Kanno, Masatoshi
    BLOOD, 2015, 126 (23)
  • [20] Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments
    Castelli, Roberto
    Gidaro, Antonio
    Deliliers, Giorgio L.
    Bergamaschini, Luigi
    ANTI-CANCER DRUGS, 2021, 32 (03) : 323 - 329